Stoke Therapeutics (STOK) Other Gross PP&E Adjustments: 2022-2025
Historic Other Gross PP&E Adjustments for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to -$5.4 million.
- Stoke Therapeutics' Other Gross PP&E Adjustments rose 18.51% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year increase of 46.86%. This contributed to the annual value of $7.3 million for FY2024, which is 5.67% down from last year.
- Latest data reveals that Stoke Therapeutics reported Other Gross PP&E Adjustments of -$5.4 million as of Q3 2025, which was down 26.08% from -$4.3 million recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Other Gross PP&E Adjustments registered a high of $7.7 million during Q4 2023, and its lowest value of -$7.8 million during Q1 2024.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$5.2 million (2023), whereas its average is -$3.2 million.
- Per our database at Business Quant, Stoke Therapeutics' Other Gross PP&E Adjustments crashed by 82.83% in 2024 and then soared by 44.21% in 2025.
- Stoke Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $5.6 million in 2022, then spiked by 38.17% to $7.7 million in 2023, then decreased by 5.67% to $7.3 million in 2024, then rose by 18.51% to -$5.4 million in 2025.
- Its last three reported values are -$5.4 million in Q3 2025, -$4.3 million for Q2 2025, and -$5.3 million during Q1 2025.